[Beta-lipoproteins in obstructive jaundice. Dosage of the 2 immunologically distinct fractions].
D000208:Acute Disease; D000818:Animals; D002769:Cholelithiasis / Q000097:blood; D002779:Cholestasis / Q000097:blood* / Q000150:complications / Q000276:immunology; D002784:Cholesterol / Q000097:blood; D003911:Dextrans; D006505:Hepatitis / Q000097:blood / Q000276:immunology; D006801:Humans; D007106:Immune Sera; D007122:Immunoelectrophoresis; D008074:Lipoproteins / Q000097:blood*; D008105:Liver Cirrhosis, Biliary / Q000097:blood / Q000276:immunology; D008113:Liver Neoplasms / Q000097:blood / Q000276:immunology; D008722:Methods; D010190:Pancreatic Neoplasms / Q000097:blood / Q000276:immunology; D011817:Rabbits
D003911:Dextrans; D007106:Immune Sera; D008074:Lipoproteins; D002784:Cholesterol
Bêta lipoprotéines au cours des ictères par rétention. Dosage des deux fractions immunologiquement distinctes.